FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034396922> ?p ?o ?g. }

• W2034396922 endingPage "3204" @default.
• W2034396922 startingPage "3203" @default.
• W2034396922 abstract "We thank Perier-Muzet et al for their comments regarding the importance of adequate dermatologic surveillance in patients with melanoma treated with a BRAF inhibitor in the adjuvant setting. We agree that the use of conventional dermoscopy (not digital dermoscopy) should be the standard of dermatologic assessment for examining pigmented skin lesions. Recently, Perier-Muzet et al reported a high rate of dermoscopic changes occurring on melanocytic lesions of patients receiving the BRAF inhibitor vemurafenib. They pointed out that almost all of the changes were observed by digital dermoscopy and were not visible by naked-eye examination. However, conventional, analog dermoscopy, which is used more commonly than digital dermoscopy in daily routine practice, was not used as a control. It remains unclear whether digital dermoscopy is superior to analog dermoscopy in identifying new primary melanomas (NPMs) in patients treated with vemurafenib. Perier-Muzet et al argued that the true effect of BRAF inhibitors on the incidence of NPMs will not be assessed in the randomized placebo-controlled adjuvant clinical trial of vemurafenib (A Phase III, Randomized, Double-Blind, Placebo-Controlled Study of Vemurafenib [RO5185426] Adjuvant Therapy in Patients With Surgically Resected, Cutaneous BRAF Mutant Melanoma at High Risk for Recurrence [BRIM8]; NCT01667419) because of the lack of protocol-driven dermoscopic surveillance. The BRIM8 protocol requires dermatologic assessment by a designateddermatologistwhoisexperiencedinthediagnosisandmanagement ofcutaneousneoplasms.Severalsurveysevaluatedtheuseofconventional dermoscopy by dermatologists in the United States, Australia, and Europe. Surveys published in 2007 and 2011 of Australian dermatologists found a high prevalence of dermoscopy use, 95% and 98%, respectively. In a US survey, 94% of dermatology chief residents used dermoscopy. In a nationwide survey conducted in academic and nonacademic hospital centers in France, 98% reported using dermoscopy. Taken together, these data suggest that most dermatologists use conventional dermoscopy for examining pigmented lesions. Given that protocol-driven dermatologic surveillance by a dermatologist is required and conventional, and analog dermoscopy is widely used by dermatologists, we adhere to our conclusion that the true effect of BRAF inhibitors on the incidence of NPMs will be assessed in the BRIM8 study. Moreover, regardless of the use of dermoscopy, because the BRIM8 study is a randomized, double-blind, placebo-controlled trial, any important difference in NPM risk should be revealed via any method of dermatologic assessment, as long as the method is consistent between both arms and for a given patient. Furthermore, use of single-agent BRAF inhibition in melanoma may decrease moving forward. The combination of the BRAF inhibitor dabrafenib and the MEK inhibitor trametinib is currently approved for use in V600 BRAF mutant metastatic melanoma in the United States and Australia because of its superior efficacy and fewer oncogenic toxicities compared with dabrafenib, and is under investigation in the adjuvant setting (NCT01682083)." @default.
• W2034396922 created "2016-06-24" @default.
• W2034396922 creator A5008839819 @default.
• W2034396922 creator A5022520811 @default.
• W2034396922 creator A5034365278 @default.
• W2034396922 creator A5035263718 @default.
• W2034396922 creator A5062978331 @default.
• W2034396922 creator A5064923908 @default.
• W2034396922 creator A5071577704 @default.
• W2034396922 creator A5083653505 @default.
• W2034396922 date "2014-10-01" @default.
• W2034396922 modified "2023-09-23" @default.
• W2034396922 title "Reply to M. Perier-Muzet et al" @default.
• W2034396922 cites W1603089681 @default.
• W2034396922 cites W1977150650 @default.
• W2034396922 cites W2059991331 @default.
• W2034396922 cites W2126956772 @default.
• W2034396922 cites W2155008712 @default.
• W2034396922 cites W2156078931 @default.
• W2034396922 cites W2410331655 @default.
• W2034396922 doi "https://doi.org/10.1200/jco.2014.56.8477" @default.
• W2034396922 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25185100" @default.
• W2034396922 hasPublicationYear "2014" @default.
• W2034396922 type Work @default.
• W2034396922 sameAs 2034396922 @default.
• W2034396922 citedByCount "3" @default.
• W2034396922 countsByYear W20343969222016 @default.
• W2034396922 countsByYear W20343969222019 @default.
• W2034396922 crossrefType "journal-article" @default.
• W2034396922 hasAuthorship W2034396922A5008839819 @default.
• W2034396922 hasAuthorship W2034396922A5022520811 @default.
• W2034396922 hasAuthorship W2034396922A5034365278 @default.
• W2034396922 hasAuthorship W2034396922A5035263718 @default.
• W2034396922 hasAuthorship W2034396922A5062978331 @default.
• W2034396922 hasAuthorship W2034396922A5064923908 @default.
• W2034396922 hasAuthorship W2034396922A5071577704 @default.
• W2034396922 hasAuthorship W2034396922A5083653505 @default.
• W2034396922 hasBestOaLocation W20343969221 @default.
• W2034396922 hasConcept C71924100 @default.
• W2034396922 hasConceptScore W2034396922C71924100 @default.
• W2034396922 hasIssue "28" @default.
• W2034396922 hasLocation W20343969221 @default.
• W2034396922 hasLocation W20343969222 @default.
• W2034396922 hasOpenAccess W2034396922 @default.
• W2034396922 hasPrimaryLocation W20343969221 @default.
• W2034396922 hasRelatedWork W1506200166 @default.
• W2034396922 hasRelatedWork W1995515455 @default.
• W2034396922 hasRelatedWork W2048182022 @default.
• W2034396922 hasRelatedWork W2080531066 @default.
• W2034396922 hasRelatedWork W2604872355 @default.
• W2034396922 hasRelatedWork W2748952813 @default.
• W2034396922 hasRelatedWork W2899084033 @default.
• W2034396922 hasRelatedWork W3031052312 @default.
• W2034396922 hasRelatedWork W3032375762 @default.
• W2034396922 hasRelatedWork W3108674512 @default.
• W2034396922 hasVolume "32" @default.
• W2034396922 isParatext "false" @default.
• W2034396922 isRetracted "false" @default.
• W2034396922 magId "2034396922" @default.
• W2034396922 workType "article" @default.